or
forgot password
  • cancer clinical trials in kenton, OH

  • Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Cole, Sharon, K. M.D. (UIA Investigator)
    Kenton, Ohio 43326
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Cole, Sharon, K. M.D. (UIA Investigator)
    Kenton, Ohio 43326
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Cole, Sharon, K. M.D. (UIA Investigator)
    Kenton, Ohio 43326
    Recurrent Mantle Cell Lymphoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Cole, Sharon, K. M.D. (UIA Investigator)
    Kenton, Ohio 43326
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Cole, Sharon, K. M.D. (UIA Investigator)
    Kenton, Ohio 43326
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Office of Sharon Cole, M.D.
    Kenton, Ohio 43326
    Colorectal Cancer
    Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
    Kenton Oncology, Incorporated
    Kenton, Ohio 43326
    Hot Flashes, Prostate Cancer
    EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
    Kenton Oncology, Incorporated
    Kenton, Ohio 43326
    Breast Cancer, Neurotoxicity
    Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
    Kenton Oncology, Incorporated
    Kenton, Ohio 43326
    Breast Cancer, Osteoporosis
    Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
    Kenton Oncology, Incorporated
    Kenton, Ohio 43326
    Pain, Unspecified Adult Solid Tumor, Protocol Specific
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Kenton Oncology, Incorporated
    Kenton, Ohio 43326
    Pancreatic Cancer
    Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
    Kenton Oncology, Incorporated
    Kenton, Ohio 43326
    Breast Cancer
    Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
    Kenton Oncology, Incorporated
    Kenton, Ohio 43326
    Esophageal Cancer
    ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer
    Kenton Oncology, Incorporated
    Kenton, Ohio 43326
    Breast Cancer
    Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
    Kenton Oncology, Incorporated
    Kenton, Ohio 43326
    Pancreatic Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Kenton Oncology, Incorporated
    Kenton, Ohio 43326
    Breast Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Cole, Sharon, K. M.D. (UIA Investigator)
    Kenton, Ohio 43326
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer